BioCardia BCDA
NASDAQ BCDA
$1.02 +0.01 (+0.99%)
At close: Oct 1, 2026 · 4:00 PM EDT

BioCardia (BCDA) Non-Current Deffered Revenue (2019 - 2020)

Updated

BioCardia (BCDA) recorded Non-Current Deffered Revenue of $683,000 in Q3 2020, down 1.2% from $691,000 a year earlier and down 0.9% from the prior quarter.

Analysis

BioCardia (BCDA) Non-Current Deffered Revenue (2019 - 2020) Analysis & Trends

At the end of FY2019, BioCardia reported Non-Current Deffered Revenue of $691,000.

  • Per Business Quant, the preceding three quarters came in at $689,000 (Q2 2020), $689,000 (Q1 2020) and $691,000 (Q4 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 BioCardia 12.21 Mn -649,799.44 - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 683,000.00
Jun 30, 2020 689,000.00
Mar 31, 2020 689,000.00
Dec 31, 2019 691,000.00
Sep 30, 2019 691,000.00
API Access

BioCardia Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BCDA&period=max&api_key=YOUR_API_KEY